Patent · US Active

Asymmetric ureas and medical uses thereof

US10407390B2 · kind B2 · utility

0Cited by

3References

3Claims

0Family size

Assignee

Helsinn Healthcare SA · CH

Inventors

Silvina Garcia Rubio · Princeton, US
Claudio Pietra · Como, IT
Claudio Giuliano · Como, IT
Zhigang Li · Fryeburg, US

Key dates

Filing date	Jul 30, 2017
Grant date	Sep 10, 2019
Priority date	—
Expiry date	Jul 30, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.